Antibodies and molecules derived therefrom that bind to STEAP-1 proteins

Antibodies and molecules derived therefrom that bind to novel STEAP-1 protein, and variants thereof, are described wherein STEAP-1 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, STEAP-1 provides a diagnostic, pr...

Full description

Saved in:
Bibliographic Details
Main Authors CHALLITA-EID PIA M, RAITANO ARTHUR B, ETESSAMI SOUDABEH, FARIS MARY, PEREZ-VILLAR JUAN J, MORRISON KAREN J, GUDAS JEAN, JAKOBOVITS AYA, JIA XIAOI
Format Patent
LanguageEnglish
Published 05.05.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Antibodies and molecules derived therefrom that bind to novel STEAP-1 protein, and variants thereof, are described wherein STEAP-1 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, STEAP-1 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The STEAP-1 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with STEAP-1 can be used in active or passive immunization.
Bibliography:Application Number: US201113136897